158 related articles for article (PubMed ID: 23344412)
1. Maternal hemolysis after intravenous immunoglobulin treatment in fetal and neonatal alloimmune thrombocytopenia.
Rink BD; Gonik B; Chmait RH; O'Shaughnessy R
Obstet Gynecol; 2013 Feb; 121(2 Pt 2 Suppl 1):471-3. PubMed ID: 23344412
[TBL] [Abstract][Full Text] [Related]
2. Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia.
Lakkaraja M; Jin JC; Manotas KC; Vinograd CA; Ferd P; Gabor J; Wissert M; Berkowitz RL; McFarland JG; Bussel JB
Transfusion; 2016 Oct; 56(10):2449-2454. PubMed ID: 27611703
[TBL] [Abstract][Full Text] [Related]
3. The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia.
Thung SF; Grobman WA
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1094-9. PubMed ID: 16157118
[TBL] [Abstract][Full Text] [Related]
4. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
[TBL] [Abstract][Full Text] [Related]
5. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB
Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin-related hemolysis in patients treated for Kawasaki disease.
Luban NL; Wong EC; Henrich Lobo R; Pary P; Duke S
Transfusion; 2015 Jul; 55 Suppl 2():S90-4. PubMed ID: 26174904
[TBL] [Abstract][Full Text] [Related]
7. Antenatal invasive and noninvasive management of alloimmune thrombocytopenia.
Kornfeld I; Wilson RD; Ballem P; Wittmann BK; Farquharson DF
Fetal Diagn Ther; 1996; 11(3):210-7. PubMed ID: 8739589
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose versus Standard-Dose Intravenous Immunoglobulin to Prevent Fetal Intracranial Hemorrhage in Fetal and Neonatal Alloimmune Thrombocytopenia: A Randomized Trial.
Paridaans NP; Kamphuis MM; Taune Wikman A; Tiblad E; Van den Akker ES; Lopriore E; Challis D; Westgren M; Oepkes D
Fetal Diagn Ther; 2015; 38(2):147-53. PubMed ID: 25896635
[TBL] [Abstract][Full Text] [Related]
9. Hemolysis upon intravenous immunoglobulin transfusion.
Padmore RF
Transfus Apher Sci; 2012 Feb; 46(1):93-6. PubMed ID: 22169381
[TBL] [Abstract][Full Text] [Related]
10. Obstetric uses of intravenous immunoglobulin: successes, failures, and promises.
Branch DW; Porter TF; Paidas MJ; Belfort MA; Gonik B
J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S133-8. PubMed ID: 11586281
[TBL] [Abstract][Full Text] [Related]
11. Direct fetal administration of immunoglobulins: another disappointing therapy in alloimmune thrombocytopenia.
Weiner E; Zosmer N; Bajoria R; Sepulveda W; Vaughan JI; Letsky EA; Fisk NM
Fetal Diagn Ther; 1994; 9(3):159-64. PubMed ID: 8060511
[TBL] [Abstract][Full Text] [Related]
12. Lower-dose intravenous immunoglobulins for the treatment of fetal and neonatal alloimmune thrombocytopenia: a cohort study.
Kamphuis M; Paridaans N; Winkelhorst D; Wikman A; Tiblad E; Lopriore E; Westgren M; Oepkes D
Transfusion; 2016 Sep; 56(9):2308-13. PubMed ID: 27383293
[TBL] [Abstract][Full Text] [Related]
13. Hemolytic adverse events with immune globulin products: product factors and patient risks.
Scott DE; Epstein JS
Transfusion; 2015 Jul; 55 Suppl 2():S2-5. PubMed ID: 26174893
[No Abstract] [Full Text] [Related]
14. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
Berkowitz RL; Kolb EA; McFarland JG; Wissert M; Primani A; Lesser M; Bussel JB
Obstet Gynecol; 2006 Jan; 107(1):91-6. PubMed ID: 16394045
[TBL] [Abstract][Full Text] [Related]
15. Fetal alloimmune thrombocytopenia and maternal intravenous immunoglobulin infusion.
Giers G; Wenzel F; Stockschläder M; Riethmacher R; Lorenz H; Tutschek B
Haematologica; 2010 Nov; 95(11):1921-6. PubMed ID: 20534698
[TBL] [Abstract][Full Text] [Related]
16. Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy.
Althaus J; Weir EG; Askin F; Kickler TS; Blakemore K
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1100-4. PubMed ID: 16157119
[TBL] [Abstract][Full Text] [Related]
17. Transfusions of least-incompatible blood with intravenous immunoglobulin plus steroids cover in two patients with rare antibody.
Win N; Needs M; Thornton N; Webster R; Chang C
Transfusion; 2018 Jul; 58(7):1626-1630. PubMed ID: 29732576
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage.
Kanhai HH; van den Akker ES; Walther FJ; Brand A
Fetal Diagn Ther; 2006; 21(1):55-60. PubMed ID: 16354976
[TBL] [Abstract][Full Text] [Related]
19. Fetal anemia as a response to prophylactic platelet transfusion in the management of alloimmune thrombocytopenia.
Yeast JD; Plapp F
Am J Obstet Gynecol; 2003 Sep; 189(3):874-6. PubMed ID: 14526332
[TBL] [Abstract][Full Text] [Related]
20. Antenatal treatment of neonatal alloimmune thrombocytopenia.
Bussel JB; Berkowitz RL; McFarland JG; Lynch L; Chitkara U
N Engl J Med; 1988 Nov; 319(21):1374-8. PubMed ID: 3141811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
